Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BFI Finance Indonesia Tbk (BFIN) vs Merck Tbk. (MERK) Price & Performance

BFI Finance Indonesia TbkTrade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

BFI Finance Indonesia Tbk vs Merck Tbk. — how do they compare? BFI Finance Indonesia Tbk trades at Rp910 (market cap 13.76T, 10.48M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: BFI Finance Indonesia Tbk is far larger — about 7.9× Merck Tbk.'s market cap, and BFI Finance Indonesia Tbk is more actively traded (10.48M versus 29.1K). Which is the better fit depends on your goals.

BFINMERK
Market Cap
13.76T1.75T
Volume
10.48M29.1K
Lot
104.8K291
Turnover
9.55B113.37M
Average Price
910.983,895.98
Value
9.55B113.37M
Indicative Equilibrium Price
9103,890
Indicative Equilibrium Volume
1.29K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BFIN
View details
MERK
View details

About BFI Finance Indonesia Tbk

PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001

Read more on BFIN

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK